
TOKYO -- Takeda Pharmaceutical plans to sell its Osaka headquarters to bolster its finances ahead of the planned purchase of Irish drugmaker Shire for nearly 7 trillion yen ($63 billion) .
Sale aimed at beefing up finances for the planned $63bn acquisition
TOKYO -- Takeda Pharmaceutical plans to sell its Osaka headquarters to bolster its finances ahead of the planned purchase of Irish drugmaker Shire for nearly 7 trillion yen ($63 billion) .
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.